Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and Females

Inclusion: 1. Men or non-pregnant, non-lactating women, 18 to 45 years of age inclusive on study day 1. 2. Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram (ECG) 3. Nonsmoker or smoker of fewer than 10 cigarettes (half a pack) a day. Exclusion: 1. Any significant cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease. 2. History of epilepsy or seizure disorder (except history of a single childhood febrile seizure).